Risk of Advanced Colorectal Neoplasia Higher Among Some Survivors of Hodgkin Lymphoma
Researchers present results of an interim analysis of a study on the prevalence of advanced colorectal neoplasia among survivors of Hodgkin lymphoma.
Hodgkin Lymphoma
Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
A retrospective evaluation of patients treated at a tertiary cancer center demonstrated that patients with Hodgkin lymphoma experienced periods of actionable distress in survivorship, despite a low overall distress burden.
Cost of Brentuximab Vedotin as First-Line Therapy for Advanced Hodgkin Lymphoma Prohibitive
Although brentuximab vedotin offers clinical benefit over bleomycin in first-line treatment of adults with advanced Hodgkin lymphoma, investigators find the drug is not cost-effective.
Newer Hodgkin Lymphoma Regimens Are Less Toxic, But Still Impose Reproductive Risks
A substudy of a multinational study sought to determine the risk to ovarian function with ABVD, AVD, and BEACOPP regimens on ovarian function in women with Hodgkin lymphoma.
Pulmonary Toxicity Increased in Pediatric Hodgkin Lymphoma Treated With Brentuximab Vedotin
A retrospective study evaluated the efficacy vs pulmonary toxicity of brentuximab vedotin for relapsed or refractory Hodgkin lymphoma in pediatric patients.
Fertility Preservation in Hodgkin’s Lymphoma Patients That Undergo Targeted Molecular Therapies: An Important Step Forward From the Chemotherapy Era
[Cancer Management and Research] A review of fertility complications induced by chemotherapy and radiotherapy, as well as possible treatment options for HL patients with fertility problems.
Long-term Survival Improving Over Time in Advanced Hodgkin Lymphoma
A review of SEER data revealed trends in incidence of advanced Hodgkin lymphoma, discrepancies among subgroups, and survival over 3 decades.
Fifth Indication for Brentuximab Vedotin Is a First for cHL Therapy in 40+ Years
FDA approval was granted based on findings from the open-label phase 3 ECHELON-1 study.
18F-FDG PET/CT Accurately Identifies Bone Marrow Involvement in Pediatric Hodgkin’s Lymphoma
Researchers conducted a retrospective study to assess 18F-FDG PET/CT vs bone marrow biopsy to detect bone marrow involvement among pediatric patients with Hodgkin lymphoma.
Physical Inactivity Linked With Increased Risk of Hodgkin, Non-Hodgkin Lymphoma
In a case-control study using PEDS data, researchers determined the impact of inactivity on risk for Hodgkin lymphoma and non-Hodgkin lymphoma.
